Periconceptional multivitamin use and the occurrence of conotruncal heart defects: Results from a population-based, case-control study

Pediatrics

Volumn 98, Issue 5, 1996, Pages 911-917

  Botto, Lorenzo D ^a,b   Khoury, Muin J ^a   Mulinare, Joseph ^a   Erickson, J David ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

congenital heart defect; conotruncal; malformation; prevention; vitamins

Indexed keywords

ADULT; ARTICLE; DISEASE ASSOCIATION; FALLOT TETRALOGY; FEMALE; GREAT VESSELS TRANSPOSITION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL NUTRITION; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; RISK ASSESSMENT; VITAMIN INTAKE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; FEMALE; FERTILIZATION; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; PREGNANCY; TETRALOGY OF FALLOT; TRANSPOSITION OF GREAT VESSELS; TRUNCUS ARTERIOSUS, PERSISTENT; VITAMINS;

EID: 0029959091     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Adams FH, Emmanouilides GC, Riemenschneider TA, eds. Heart Disease in Infants, Children, and Adolescents. Baltimore, MD: Williams & Wilkins; 1989
2. Adams MA, Mulinare J, Dooley K. Risk factors for conotruncal heart defects in Atlanta. J Am Coll Cardiol. 1989;14:432-442
3. Ferencz C, Loffredo CA, Rubin JD, Magee CA, eds. Epidemiology of Congenital Heart Disease. The Baltimore-Washington Infant Study 1981-1989. Perspectives in Pediatric Cardiology. Vol 4. Mt Kisco, NY: Futura Publishing Co; 1993
4. Pradat P. Epidemiology of major congenital heart defects in Sweden, 1981-1986. J Epidemol Community Health. 1992;46:211-215
5. Francannet C, Lancaster PAL, Pradat P, Cocchi G, Stoll C. The epidemiology of three serious cardiac defects. A joint study between five centers. Eur J Epidemiol. 1993;9:607-616
6. Czeizel AE, Intody Z, Modell B. What proportion of congenital abnormalities can be prevented? Br Med J. 1993;306:499-503
7. Kirklin JW, Blackstone EH, Jonas RA, et al. Morphologic and surgical determinants of outcome events after repair of tetralogy of Fallot and pulmonary stenosis. A two-institution study. J Thorac Cardiovasc Surg. 1992;103:706-723
8. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993; 329:593-599
9. Kirklin JW, Colvin EV, McConnell ME, Bargeron LM Jr. Complete transposition of the great arteries: treatment in the current era. Pediatr Clin North Am. 1990;37:171-177
10. Pacifico AD, Kirklin JK, Colvin EV, McConnell ME, Kirklin JW. Tetralogy of Fallot: late results and reoperations. Semin Thorac Cardiovasc Surg. 1990;2:108-116
11. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet. 1980;1:339-340
12. Smithells RW, Sheppard S, Wild J, Schorah CJ. Prevention of neural tube defects recurrences in Yorkshire: final report. Lancet. 1989;2:498-499
13. Mulinare J, Cordero J, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;: 260:3141-3145
14. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defect: evidence from a case-control study in Western Australia. Med J Aust. 1989;150:613-619
15. Bower C, Stanley FJ. Periconceptional vitamin supplementation and neural-tube defect: evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health. 1992;46:157-161
16. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262:2847-2852
17. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835
18. Laurence KM, James M, Miller MH, Tennant JB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J. 1981;282: 1509-1511
19. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn. 1990;10:149-152
20. Medical Research Council Vitamin Study Research Group. Prevention of neural-tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137
21. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br Med J. 1993;306:1645-1648
22. Erickson JD, Mulinare J, McClain PW, et al. Vietnam veterans' risks for fathering babies with birth defects. JAMA. 1984;252:903-912
23. Erickson JD, Mulinare J, McClain PW, et al. Vietnam Veterans' Risks for Fathering Babies with Birth Defects. Atlanta, GA: Centers for Disease Control; 1984
24. Werler MM, Pober BR, Nelson K, Holmes LB. Reporting accuracy among mothers of malformed and non-malformed infants. Am J Epidemiol. 1989;129:415-421
25. Feldman Y, Koren G, Mattice D, Shear H, Pellegrini E, McCleod SM. Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. Teratology. 1989;40:37-45
26. McKenzie SG, Lippman A. An investigation of reporting bias in a case-control study of pregnancy outcome. Am J Epidemiol. 1989;129: 65-75
27. Källén B. Epidemiology of Human Reproduction. Boca Raton, FL: CRC Press; 1988:72-73
28. Swan SH, Shaw GM, Schulman J. Reporting and selection bias in case-control studies of congenital malformations. Epidemiology. 1992;3: 356-363
29. Drews C, Greenland S, Flanders WD. The use of restricted controls to prevent recall bias in case-control studies of reproductive outcomes. Ann Epidemiol. 1993;3:86-92
30. Khoury MJ, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology. 1994;49:273-281
31. Ferencz C, Rubin JD, McCarter RJ, Clark EB. Maternal diabetes and cardiovascular malformations: predominance of double-outlet right ventricle and truncus arteriosus. Teratology. 1990;41:319-326
32. Becerra J, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1-9
33. Greenberg F. DiGeorge syndrome: an historical overview of clinical and cytogenetic features. J Med Genet. 1993;30:803-806
34. Greenberg F, Elder FFB, Haffner P, Northrup H, Ledbetter D. Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Hum Genet. 1988;434:605-611
35. Wilson DI, Burn J, Scambler P, Goodship J. Syndrome of the month. DiGeorge syndrome, part of CATCH-22. J Med Genet. 1993;30:852-856
36. Budarf ML, Collins J, Gong W, et al. Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet. 1995;10:269-278
37. Goldmuntz E, Driscoll D, Budarf ML, et al. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet. 1993;30:807-812
38. Limb CJ, Holmes LB. Anencephaly: changes in prenatal detection and birth status, 1972 through 1990. Am J Obstet Gynecol 1994;170:1333-1338
39. Kalucy M, Bower C, Stanley F, Burton P. Survival of infants with neural tube defects in Western Australia 1966-1990. Paediatr Perinat Epidemiol. 1994;8:334-351
40. Krivchenia E, Huether CA, Edmonds LD, May DS, Guckenberger S. Comparative epidemiology of Down syndrome in two United States populations, 1970-1989. Am J Epidemiol. 1993;137:815-828
41. Allan LD, Cook A, Sullivan I, Sharland GK. Hypoplastic left heart syndrome: effects of fetal echocardiography on birth prevalence. Lancet. 1991;337:959-961
42. Warkany J. Disturbance of embryonic development by maternal vitamin deficiency. J Cell Comp Physiol. 1954;53(suppl):207-236
43. Mills JL, Rhoads GG, Simpson JL, et al. The absence of a relation between the periconceptional use of vitamins and neural tube defects. N Engl J Med. 1989;321:430-435
44. Shaw GM, Wasserman CR, O'Malley CD. Periconceptional vitamin use and reduced risk for conotruncal and limb defects in California. Teratology. 1994;49:372
45. Milunsky A, Alpert E, Kitzmiller JL, Younge MD, Neff RK. Prenatal diagnosis of neural rube defects. The importance of serum alphafetoprotein in diabetic pregnant women. Am J Obstet Gynecol. 1982;142: 1030-1032
46. Monie IW, Nelson MM. Abnormalities of the pulmonary and other vessels in rat fetuses from maternal pteroylglutamic acid deficiency. Anat Rec. 1963;147:397-401
47. Baird CDC, Nelson MM, Monie IW, Evans HM. Congenital cardiovascular anomalies induced by pteroylglutamic acid deficiency during gestation in the rat. Circ Res. 1954;2:544-548
48. McCredie J. Embryonic neuropathy: an hypothesis of neural crest injury as the pathogenesis of congenital malformations. Med J Aust. 1974;1: 159-163
49. Kirby ML, Waldo KL. Role of the neural crest in congenital heart diseases. Circulation. 1990;82:332-340
50. Moore KL. The cardiovascular system. In: The Developing Human. Philadelphia: WB Saunders Co; 1988:303-314
51. 12 as independent risk factors for neural tube defects. Q J Med. 1993;86:703-708
52. Mills JL, McPartlin JM, Peader NK, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345: 149-151
53. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in a elderly population. JAMA. 1993;270:2693-2698
54. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994;236:633-641
55. Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med. 1985;313:837-841
56. Werler MM, Lammer EJ, Rosenberg L, Mitchell AA. Maternal vitamin A supplementation in relation to selected birth defects. Teratology. 1990; 42:497-503
57. Martinez-Frias ML, Salvador J. Epidemiologic aspects of prenatal exposure to high doses of vitamin A in Spain. Eur J Epidemiol. 1990;6:118-123
58. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333:1369-1373
59. Teratology Society. Position paper: recommendations for vitamin A use during pregnancy. Teratology. 1987;35:269-275